Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net (loss)	$ (331,364)	$ (305,510)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Common stock issued for services rendered	62,263	207,035
Amortization of discount to note payable	21,918
Derivative expense	512,637
Changes in fair value of derivative liabilities	(567,016)
Accounts payable and accrued expenses	(69,384)	9,100
Due from related party	(102,120)	(12,296)
Net cash (used in) operating activities:	(473,066)	(101,671)
Cash flows from investing activities
Patent		(7,000)
Net cash (used in) investing activities:		(7,000)
Proceeds from issuance of common stock	97,500	250,000
Proceeds from exercise of warrants	78,500
Proceeds from issuance of note payable	2,400,000
Net cash provided by financing activities	2,576,000	250,000
Net increase/(decrease) in cash and cash equivalents	2,102,934	141,329
Cash and cash equivalents, beginning of year	95,069	152,526
Cash and cash equivalents, end of year	2,198,003	293,855
Interest
Income taxes